First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics
Top Cited Papers
Open Access
- 23 April 2008
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (5) , 493-502
- https://doi.org/10.1002/uog.5332
Abstract
Objectives: To use multiple regression analysis to define the contribution of maternal variables that influence the measured concentration of free beta‐human chorionic gonadotropin (β‐hCG) and pregnancy‐associated plasma protein‐A (PAPP‐A), and the interaction between these covariates, in first‐trimester biochemical screening for trisomy 21.Methods: This was a multicenter study of prospective screening for trisomy 21 by a combination of fetal nuchal translucency thickness, and maternal serum free β‐hCG and PAPP‐A at 11 + 0 to 13 + 6 weeks of gestation. In the pregnancies subsequently found to have trisomy 21 and in those with no obvious chromosomal abnormality, we used multiple regression analysis to account for pregnancy characteristics that influence the measured concentrations of free β‐hCG and PAPP‐A. We fitted Gaussian distributions to the distribution of log multiples of the median (MoM) values in trisomy 21 and in unaffected pregnancies.Results: There were 491 cases of trisomy 21 and 96 803 chromosomally normal pregnancies. Compared with values in Caucasian women, those who were parous, non‐smokers and those who conceived spontaneously, PAPP‐A was 57% higher in women of Afro‐Caribbean origin, 3% higher in South Asians, 9% higher in East Asians, 2% higher in nulliparous women, 17% lower in smokers and 10% lower in those conceiving by in‐vitro fertilization (IVF). Free β‐hCG was 12% higher in women of Afro‐Caribbean origin, 9% lower in South Asians, 8% higher in East Asians, 2% higher in nulliparous women, 4% lower in smokers and 9% higher in those conceiving by IVF. In screening for trisomy 21 by maternal age and serum free β‐hCG and PAPP‐A the estimated detection rate was 65% for a false‐positive rate of 5%.Conclusions: In first‐trimester biochemical screening for trisomy 21 it is essential to adjust the measured values of free β‐hCG and PAPP‐A for maternal and pregnancy characteristics. Copyright © 2008 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- Dose dependency between cigarette consumption and reduced maternal serum PAPP‐A levels at 11–13+6 weeks of gestationPrenatal Diagnosis, 2007
- Comparison of Serum Markers in First-Trimester Down Syndrome ScreeningObstetrics & Gynecology, 2006
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnanciesAmerican Journal of Obstetrics and Gynecology, 2005
- Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populationsPrenatal Diagnosis, 2005
- Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screeningUltrasound in Obstetrics & Gynecology, 2005
- The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancyPrenatal Diagnosis, 2004
- Maternal weight correction of maternal serum PAPP‐A and free β‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancyPrenatal Diagnosis, 2003
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTSBJOG: An International Journal of Obstetrics and Gynaecology, 1975